Marek has over 20 years of experience in clinical research in oncology (haematology and solid tumours), neuropsychiatry, diabetes and cardiovascular fields.

He brings international expert knowledge and experience in clinical operations.

During his career, Marek has been responsible for launching and managing global phase I - IV clinical studies, including large scale morbid-mortality trials.

Previously to WPD, Marek spent over 20 years in Director level roles at Servier, an international pharmaceutical company headquartered in France.

During his time at Servier, Marek served as Director, Clinical Operations (Oncology) in France, and Director, Clinical Research in Australia.

Marek was trained as an OBGYN in Poland and completed his postdoctoral fellowship at the National Cancer Institute, Bethesda, US.

https://www.globenewswire.com/news-release/2020/10/15/2109097/0/en/WPD-Pharmaceuticals-Appoints-New-Chief-Medical-Officer-to-Lead-Phase-I-and-II-Clinic-Trials.html